ImageneBio (IMA) Earnings Date & Reports

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMA is expected to report earnings to rise 4.35% to -72 cents per share on November 06

Q3'25

Est.

$-0.72

Q2'25

Missed

by $0.55

The last earnings report on July 24 showed earnings per share of -68 cents, missing the estimate of -14 cents. With 5.89K shares outstanding, the current market capitalization sits at 164.04M.

View a ticker or compare two or three

Compare

IMA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMA showed earnings on July 24, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details